Pharmaron controlling shareholder adjusts equity, investment partnerships reduce holdings

Pharmaron Beijing (SZSE:300759) announced that its actual controlling person, Lou Xiaoqiang, pledged 5.22m shares (0.29% of total share capital) for financing. Concurrently, concerted parties Ningbo Longtaikang Investment Management Co., Ltd. and Beihai Duotai Venture Capital Co., Ltd. released 6.93m pledged shares (0.39% of total share capital) and extended the repurchase period for 15.97m pledged shares (0.90% of total share capital) for financing. These actions maintain that pledged shares are not subject to major asset restructuring or performance compensation liabilities.

In a separate announcement, Shenzhen Xinchuangkangcheng Investment Partnership (LP) and Shenzhen Xinchuanglongcheng Investment Partnership (LP), shareholders holding over 5% of Pharmaron Beijing, completed their previously announced share reduction plan. Xinchuangkangcheng sold 8.89m shares (0.50% of total share capital) via block trade at an average price of CNY 28.93. Xinchuanglongcheng sold 17.78m shares (1.00% of total share capital) via centralized bidding at an average price of CNY 29.24. The total reduction amounted to 26.67m shares (1.50% of total share capital).

Following these transactions, the actual controlling person and their concerted parties affirm that their pledged shares do not face liquidation risks and these activities will not change the company's control or impact its operations.